> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Hemophilia Product Development
- URL: https://www.fdaweb.com/workshop-on-hemophilia-product-development/
- Published: 2018-11-02T12:00:00.000Z
- Updated: 2026-09-15T00:42:12.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142735

*Federal Register* notice: FDA has announced a 12/6 public workshop entitled “Product Development in Hemophilia.” The workshop is intended to advance further development of patient- experience and patient-reported outcomes for use in clinical trials, facilitate reliable and interpretable measurements of Factor VIII/IX activity levels for gene therapy products, discuss the need for long-term safety assessments in gene therapy clinical trials, and discern when to enroll pediatric patients in gene therapy trials. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-11-02/pdf/2018-23947.pdf?ref=fdaweb.com).